Your Cart ( 1 Item )

• Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy
  July 2018 | Volume 17 | Issue 7 | Original Article | 723 | Copyright © July 2018
  David M. Pariser MD,^a Lawrence J. Green MD,^b Linda Stein Gold MD,^c Jeffrey L. Sugarman MD PhD,^d Tina Lin PharmD,^e Radhakrishnan Pillai PhD^f
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs